Dara Manoach, Ph.D. Person: Professor of Psychology at Department of Psychiatry at Harvard Medical School
Anna awarded ASN Young Investigator Award! News: October 21, 2020 Read more about the Donald W. Seldin Young Investigator Award here.
Vignesh Shanmugam Person: Postdoctoral Fellow I am a hematopathologist with interests in applying single cell and tissue imaging technologies to better understand the biology of lymphoid malignancies and develop new diagnostic approaches.
Mounica Vallurupalli Person: Postdoctoral Fellow I am a physician-scientist interested in functional genomics, transcriptional regulation and myeloid disease biology.
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome Publication: Journal Article Ebert, B. L., N. Galili, P. Tamayo, J. Bosco, R. Mak, J. Pretz, S. Tanguturi, et al. 2008. “An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome”. PLoS Med 5: e35.
Cas9 activates the p53 pathway and selects for p53-inactivating mutations Publication: Journal Article Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 662-68.
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations Publication: Journal Article Enache, O. M., V. Rendo, M. Abdusamad, D. Lam, D. Davison, S. Pal, N. Currimjee, et al. 2020. “Author Correction: Cas9 Activates the P53 Pathway and Selects for P53-Inactivating Mutations”. Nat Genet 52: 748-49.
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia Publication: Journal Article Ferrando, A. A., D. S. Neuberg, J. Staunton, M. L. Loh, C. Huard, S. C. Raimondi, F. G. Behm, et al. 2002. “Gene Expression Signatures Define Novel Oncogenic Pathways in T Cell Acute Lymphoblastic Leukemia”. Cancer Cell 1: 75-87.
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma Publication: Journal Article Fuchs, B. C., Y. Hoshida, T. Fujii, L. Wei, S. Yamada, G. Y. Lauwers, C. M. McGinn, et al. 2014. “Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma”. Hepatology 59: 1577-90.